



Supporting Your Regional Pharmacovigilance Needs with Our QPPVs & LPPVs
A Qualified Person Responsible for Pharmacovigilance (QPPV) is an individual who is appointed by a pharmaceutical company to ensure the compliance of its pharmacovigilance system with regulatory requirements. The QPPV is responsible for overseeing the safety of the company’s medicinal products and ensuring that any adverse events related to the use of these products are reported and handled in accordance with applicable regulations.
LPPVs are responsible for the local implementation of pharmacovigilance activities in individual countries, including the collection and reporting of adverse event data. They work closely with QPPVs to ensure that safety information is communicated effectively across borders.
We deliver QPPV & LPPV services leveraging our TOTALVigilance framework and our affiliates, staretgic partners across the globe a cost-effective, flexible, and scalable solution designed to enhance your regulatory complaince and real-time oversight. It combines qualified resources, knowledge, lean processes, and modern technology to deliver high-quality, compliant services. With adaptable service models and seamless integration into your existing systems and workflows, TOTALVigilance enhances operational efficiency, enables proactive oversight, and maximizes return on investment.
Services We Offer
At Techsol, our QPPV Professionals are experts in overseeing the pharmacovigilance activities for a pharmaceutical company on a European Union (EU) level. Our QPPV’s ensure that our clients’ comply with the EU pharmacovigilance regulations related to drug safety.
Our Local Person for Pharmacovigilance (LPPV) expert resources, on the other hand, help clients’ to carry out local pharmacovigilance activities within a specific EU member state. Our LPPV professionals collaborate with our QPPV for the implementation of the pharmacovigilance system at the local level. This includes the collection, documentation, and reporting of adverse drug reactions.
Our team of experts has extensive experience in the pharmaceutical and medical device industries and can provide you with practical advice and support that is grounded in the latest regulatory guidance.
How We Can Help
- Acting as your QPPV and LPPV, providing expert guidance and support on all aspects of pharmacovigilance.
- Establishing and maintaining your pharmacovigilance system, including the development of standard operating procedures and the creation of safety data exchange agreements.
- Overseeing the collection, evaluation, and reporting of adverse event data.
- Liaising with regulatory authorities on your behalf.
- Providing training and support to your staff on pharmacovigilance activities.
- Always meeting timelines and avoiding delays

TOTALVigilance Services
End-to-End Pharmacovigilance Solutions
Pharmacovigilance Technology Solutions
Leverage our 15+ years of comprehensive experience and our portfolio of System Integration (SI) and Managed Cloud Services to enhance regulatory compliance in pharmacovigilance.
Pharmacovigilance Operations Oversight & Agentic AI Solutions
Manual oversight is often inefficient and error-prone, leading to compliance risks. As a result, there is a growing need for a digital, automated PV oversight framework to enhance efficiency, data quality, and real-time regulatory compliance
Operations Oversight & Agentic AI Platform – Compier PV Ops
Unique SaaS platform that co-exist with drug safety databases enable companies to proactively manage and automate global Pharmacovigilance compliance operations.
Integrated & Automated Functional Services
Life sciences organizations need a modern delivery framework that is purpose-built for agility, scalability, and compliance to efficiently address all of the regulatory obligations towards Pharmacovigilance.
TOTALVigilance - Functional Services
Simplify End-to-End Pharmacovigilance Compliance Obligations by combining People, Process, Technology, Automation & Quality.
Latest Relevant Case Studies

December 29, 2022
Establishing an Integrated Global Drug Safety and Signal Management Cloud Solution

December 29, 2022
Argus Safety Cloud Implementation and Validation on Oracle Cloud for HUGEL Pharma

December 29, 2022
Serious Adverse Event (SAE) Management, Review and Reporting to DCGI during the COVID 19 Pandemic for an Ophthalmology Clinical Study
Latest Relevant Insights

August 30, 2021
Literature Screening – Process overview, challenges en-route and the scope for automation
If you are looking for expert support with your pharmacovigilance activities, we would be delighted to hear from you. Please contact us to discuss your requirements and find out how we can help you stay compliant, reduce risk, and focus on developing life-changing products.